1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Israel >
  5. Revium Rx Acquires Lipovation

M&A Deal Summary

Revium Rx Acquires Lipovation

On February 4, 2025, Revium Rx acquired life science company Lipovation

Acquisition Highlights
  • This is Revium Rx’s 1st transaction in the Life Science sector.
  • This is Revium Rx’s 1st transaction in Israel.

M&A Deal Summary
Date 2025-02-04
Target Lipovation
Sector Life Science
Buyer(s) Revium Rx
Deal Type Add-on Acquisition

Target

Lipovation

Herzliya, Israel
Lipovation is an Israeli development-stage company specializing in lipid-based nano/micro particle medicines. Lipovation is based in Herzliya, Israel.

Search 214,600 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Revium Rx

Herzliya, Israel
Category Company
Sector Life Science
Employees3
DESCRIPTION

Revium Rx develops advanced delivery systems for various indications. The company utilizes a novel drug delivery technology to develop encapsulated therapeutics for several therapeutic indications, including antibiotics for antimicrobial-resistant bacteria, a lipid-based adjuvant for solid carcinogenic tumors, and immunization. Revium Rx is based in Herzliya, Israel.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Israel M&A 1 of 1
Year: 2025 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal